Few were ready when a mysterious respiratory illness emerged in Wuhan, China in January 2020. Politicians, government officials, business leaders, and public-health professionals were unprepared for the most devastating pandemic in a century. Many of the world’s biggest drug and vaccine makers were slow to react or couldn’t muster an effective response.
It was up to a small group of unlikely and untested scientists and executives to save civilization. A French businessman dismissed by many as a fabulist. A Turkish immigrant with little virus experience. A quirky Midwesterner obsessed with insect cells. A Boston scientist employing questionable techniques. A British scientist despised by his peers. Far from the limelight, each had spent years developing innovative vaccine approaches.
Learn more about A Shot to Save the World »
GREGORY ZUCKERMAN is a Special Writer at The Wall Street Journal, a 20-year veteran of the paper and a three-time winner of the Gerald Loeb award — the highest honor in business journalism.
More about the author »
(WHM) ©2024 Gregory Zuckerman. All Rights Reserved. | Site by KPFdigital | Log in